DK3638293T5 - Sammensætninger til behandling af cancer - Google Patents

Sammensætninger til behandling af cancer Download PDF

Info

Publication number
DK3638293T5
DK3638293T5 DK18817894.1T DK18817894T DK3638293T5 DK 3638293 T5 DK3638293 T5 DK 3638293T5 DK 18817894 T DK18817894 T DK 18817894T DK 3638293 T5 DK3638293 T5 DK 3638293T5
Authority
DK
Denmark
Prior art keywords
cancer
compositions
treatment
Prior art date
Application number
DK18817894.1T
Other languages
Danish (da)
English (en)
Other versions
DK3638293T3 (da
Inventor
Lev Becker
Chang Cui
Original Assignee
Univ Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chicago filed Critical Univ Chicago
Publication of DK3638293T3 publication Critical patent/DK3638293T3/da
Application granted granted Critical
Publication of DK3638293T5 publication Critical patent/DK3638293T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/26—Endoribonucleases producing 5'-phosphomonoesters (3.1.26)
    • C12Y301/26003—Ribonuclease III (3.1.26.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21037—Leukocyte elastase (3.4.21.37), i.e. neutrophil-elastase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DK18817894.1T 2017-06-15 2018-06-15 Sammensætninger til behandling af cancer DK3638293T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762520325P 2017-06-15 2017-06-15
US201762610711P 2017-12-27 2017-12-27
PCT/US2018/037800 WO2018232273A1 (en) 2017-06-15 2018-06-15 Methods and compositions for treating cancer

Publications (2)

Publication Number Publication Date
DK3638293T3 DK3638293T3 (da) 2023-11-06
DK3638293T5 true DK3638293T5 (da) 2024-08-26

Family

ID=64659547

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18817894.1T DK3638293T5 (da) 2017-06-15 2018-06-15 Sammensætninger til behandling af cancer

Country Status (9)

Country Link
US (2) US12564623B2 (cg-RX-API-DMAC10.html)
EP (2) EP3638293B1 (cg-RX-API-DMAC10.html)
JP (3) JP7189160B2 (cg-RX-API-DMAC10.html)
CN (1) CN111032075A (cg-RX-API-DMAC10.html)
AU (1) AU2018285710B2 (cg-RX-API-DMAC10.html)
CA (1) CA3066738A1 (cg-RX-API-DMAC10.html)
DK (1) DK3638293T5 (cg-RX-API-DMAC10.html)
ES (2) ES2962985T3 (cg-RX-API-DMAC10.html)
WO (1) WO2018232273A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119015448A (zh) 2018-12-20 2024-11-26 芝加哥大学 与用于癌症疗法的治疗肽相关的方法和组合物
CN116261592A (zh) * 2020-08-18 2023-06-13 昂希莱斯制药公司 经修饰的丝氨酸蛋白酶前蛋白
EP4199947A4 (en) * 2020-08-18 2024-10-16 Onchilles Pharma, Inc. Modified porcine pancreatic elastase proteins
CN112812150A (zh) * 2021-01-29 2021-05-18 深圳海创生物科技有限公司 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用
CN113736742B (zh) * 2021-09-08 2023-07-21 河南省医药科学研究院 Prtn3基因作为肿瘤免疫治疗中激活细胞毒性免疫细胞靶点的应用
CN115040642B (zh) * 2022-06-30 2025-03-28 德博尔(成都)生物科技有限公司 一种胰弹性蛋白酶的新用途
CN118443941A (zh) * 2024-04-29 2024-08-06 山东大学齐鲁医院 中性粒细胞作为诊疗膀胱癌的靶标的应用
CN121588088A (zh) * 2025-12-30 2026-03-03 西安交通大学 Sivelestat在制备癌症放射治疗辅助药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU662104B2 (en) 1990-08-03 1995-08-24 Vertex Pharmaceuticals Incorporated Use of crosslinked crystals as a novel form of enzyme immobilization
US5698518A (en) * 1994-03-30 1997-12-16 Oklahoma Medical Research Foundation Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
WO2003083084A2 (en) * 2002-03-29 2003-10-09 Incyte Corporation Protein modification and maintenance molecules
AU2003249012A1 (en) 2002-09-30 2004-04-23 Japan As Represented By The President Of The University Of Tokyo Genes and polypeptides relating to human myeloid leukemia
JP4408615B2 (ja) 2002-10-07 2010-02-03 独立行政法人科学技術振興機構 好酸球カチオン性タンパク質を含有する組成物
US8068990B2 (en) 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ES2316997T3 (es) 2003-07-21 2009-04-16 F. Hoffmann-La Roche Ag Uso de la proteina proteinasa 3 (prn3) y del inhibidor de la elastasa leucocitaria (ileu) como un marcador para el cancer colorrectal.
US7432419B2 (en) 2004-05-14 2008-10-07 Los Alamos National Security, Llc Compositions and methods for the treatment of Pierce's disease
US20060008891A1 (en) 2004-06-23 2006-01-12 The Government Of Usa As Repersented By The Secretary, Department Of Health And Human Services Cathepsin G-related peptides as modulators of formylpeptide receptors (FPR)
US20060045881A1 (en) 2004-08-26 2006-03-02 Board Of Regents, The University Of Texas System Anti-cancer vaccines
US8501449B2 (en) * 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
MX2011000655A (es) * 2008-07-18 2011-03-21 Oragenics Inc Composiciones para la deteccion y tratamiento de cancer colorrectal.
GB201121070D0 (en) 2011-12-07 2012-01-18 Isis Innovation composition for delivery of biotherapeutics
WO2016125330A1 (ja) * 2015-02-02 2016-08-11 原 英彰 網膜再生促進薬

Also Published As

Publication number Publication date
ES2962985T3 (es) 2024-03-22
AU2018285710A1 (en) 2020-01-23
JP2023022242A (ja) 2023-02-14
JP7529754B2 (ja) 2024-08-06
JP7189160B2 (ja) 2022-12-13
ES3055526T3 (en) 2026-02-12
JP2020524141A (ja) 2020-08-13
EP4292606A2 (en) 2023-12-20
AU2018285710B2 (en) 2025-02-13
US12564623B2 (en) 2026-03-03
CA3066738A1 (en) 2018-12-20
US20260144854A1 (en) 2026-05-28
JP2024150679A (ja) 2024-10-23
CN111032075A (zh) 2020-04-17
DK3638293T3 (da) 2023-11-06
EP3638293A4 (en) 2021-03-10
EP3638293B1 (en) 2023-10-04
EP4292606B1 (en) 2025-11-12
WO2018232273A1 (en) 2018-12-20
EP4292606A3 (en) 2024-02-21
EP3638293A1 (en) 2020-04-22
US20210299234A1 (en) 2021-09-30

Similar Documents

Publication Publication Date Title
DK3431105T3 (da) Medicinsk sammensætning til behandling af cancer
DK3501542T3 (da) Esketamin til behandling af depression
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3612215T3 (da) Sammensætninger til behandling af lungeinflammation
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3288581T3 (da) Fremgangsmåde til behandling af cancer
DK3474841T3 (da) Fremgangsmåder til behandling af ar+-brystkræft
DK3785733T3 (da) Farmaceutisk sammensætning til behandling af autisme
DK3326641T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3189082T3 (da) Anti-pd-l1-konjugater til behandling af tumorer
DK3277270T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
DK3524255T3 (da) Sammensætning til behandling af acne
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3638293T3 (da) Sammensætninger til behandling af cancer
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
DK3081263T3 (da) Sammensætninger og redskaber til behandling af glaukom
DK3458052T3 (da) Kombinationsbehandling af cancer
DK3400072T3 (da) Formuleringer til behandling af blærecancer
DK4101454T3 (da) Sammensætninger til behandling af hypertension
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
DK3377094T3 (da) Virulenssvækkede bakterier til behandling af ondartede solide tumorer